ArticleBiodegradation2025
Metabolic fingerprinting to elucidate the biodegradation of phosphonoacetic acid and its impact on Penicillium metabolism.
Article in Biodegradation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The application of metabolomic analysis to the study of fungal cell physiology provides a valuable means of elucidating the metabolic diversity of fungi. This study aims to identify metabolites that distinguish the metabolism of moulds based on the phosphorus source used in the culture medium, either inorganic phosphate (Pi) or phosphonoacetic acid (PA). A targeted metabolomics approach, using LC-MS combined with chemometric tools, facilitated the identification of metabolic differences between three fungal strains of the Penicillium genus: Penicillium commune, Penicillium crustosum S2, and Penicillium funiculosum S4. The availability of PA in the medium enables P. commune to synthesize compounds that stimulate cellular responses to unfavorable environmental conditions, while activating pathways involving precursors of secondary metabolites. Comparative analysis of cell-free extracts from P. commune and P. funiculosum S4 cultured on Pi-containing medium revealed increased levels of metabolites, including tyrosine, tryptophan, glutathione, and ethyl-3-hydroxybutyrate, in both fungal extracts. Furthermore, analysis of the cell-free extracts obtained from biomass grown on a medium containing PA showed similarities between P. commune and P. crustosum S2, as well as between the two wild strains. From these results, it can be concluded that the metabolic strategies of P. commune and P. funiculosum S4 are similar when Pi is the sole phosphorus source, whereas the use of phosphonate reveals common characteristics between the P. commune strain and P. crustosum S2. These observations allowed the identification of fungal biomarkers and provided insights into the mechanisms of metabolic response to changing environmental conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.